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Abstract
Introduction: The aim was to assess the usefulness of strain elastography (SEG) in the diagnostics of two groups of thyroid nodules (TNs): 
follicular lesions (FL) with low malignancy risk (< 20.0%) and low percentage of papillary carcinomas (PTCs) among cancers as well as 
TNs with unequivocal cytology (UC) and high percentage of PTCs among cancers.
Material and methods: 168 TNs were analysed and eventually surgically treated: 100 UC (50 benign and 50 malignant — 90.0% PTCs) 
and 68 FL (60 benign, 8 malignant — 50.0% PTCs). Elasticity score (ES) and strain ratio (SR) were evaluated, and their effectiveness was 
compared with the evaluation of the number of ultrasound malignancy risk features (NoUMRFs).
Results: In the UC group the evaluation of mean values of SR and ES in both sections (meanSR, meanES) was more efficient than 
NoUMRFs analysis (AUC: 0.903 and 0.869 vs. 0.754, p < 0.05). The following thresholds: meanSR ≥ 2.01, meanES ≥ 2.5, NoUMRFs ≥ 2, 
were related to the increased malignancy risk in nodules (OR: 45.0; 23.2; 5.4, respectively), but only meanSR ≥ 2.01 was an independent 
risk factor (OR: 20.3; SEN: 86.0%, SPC: 88.0%). In the FL group, only the evaluation of tSR (SR assessed in transverse section) had the 
value of AUC > 0.7, and only the set of features: tSR ≥ 1.7 and NoUMRFs ≥ 1 increased the malignancy risk in nodules (OR: 12.0; SEN: 
75.0%, SPC: 75.0%). 
Conclusions: SEG is more reliable than conventional US in the diagnostics of TNs. The efficacy of SEG decreases with lowering percent-
age of PTCs among cancers. But in FL nodules SEG may support the selection of nodules for surgical treatment. (Endokrynol Pol 2017; 
68 (6): 610–622)
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Streszczenie
Wstęp: Celem pracy była ocena przydatności elastografii uciskowej (SEG) w diagnostyce 2 grup guzków tarczycy (TNs): zmian pęcherzy-
kowych (FL) z niskim ryzykiem złośliwości (< 20,0%) i niskim odsetkiem raków brodawkowatych (PTCs) wśród nowotworów złośliwych 
oraz TNs z jednoznaczną cytologią (UC) i wysokim odsetkiem PTCs wśród nowotworów złośliwych. 
Materiał i metody: Analizowano 168 TNs, wszystkie ostatecznie były leczone operacyjnie, 100 UC: 50 łagodnych i 50 złośliwych (90,0% 
PTCs) i 68 FL: 60 łagodnych i 8 złośliwych (50,0% PTCs). Oceniano klasę elastogramu (ES) i wskaźnik odkształenia (SR) oraz porównywano 
ich skuteczność z oceną liczby ultrasonograficznych cech ryzyka złośliwości (NoUMRFs).
Wyniki: W grupie UC ocena średnich wartości SR i ES (meanSR i meanES) z obu przekrojów była bardziej skuteczna niż ocena 
NoUMRFs (AUC: 0,903 i 0,869 v. 0,754, < 0,05). Przekroczenie progów: meanSR ≥ 2,01, meanES ≥ 2,5, NoUMRFs ≥ 2 powodowało istotny 
wzrost ryzyka złośliwości zmiany (odpowiednio OR: 45,0; 23,2; 5,4), ale tylko meanSR ≥ 2,01 był niezależnym czynnikiem ryzyka 
złośliwości (OR: 20,3; SEN: 86,0%, SPC: 88,0%). W grupie FL tylko dla tSR (SR analizowane na przekroju poprzecznym) stwierdzono 
wartość AUC > 0,7. Jednoczesne występowanie tSR ≥ 1,7 i NoUMRFs ≥ 1 istotnie zwiększało ryzyko złośliwości zmiany (OR: 12,0; 
SEN: 75,0%, SPC: 75,0%). 
Wnioski: SEG jest bardziej wiarygodna niż klasyczna ultrasonografia w diagnostyce TNs. Skuteczność SEG spada z obniżaniem się 
odsetka PTCs wśród nowotworów złośliwych. Ale także w grupie FL SEG może pomóc wyodrębnianiu TNs, które powinny być leczone 
chirurgicznie. (Endokrynol Pol 2017; 68 (6): 610–622)
Słowa kluczowe: elastografia, tarczyca, zmiany pęcherzykowe, biopsja aspiracyjna cienkoigłowa, rak tarczycy
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Introduction
The preoperative diagnostics of thyroid nodules (TNs) 
is a challenge because it requires the detection of cancers 
among many non-neoplastic lesions. Ultrasonography 
(US) and fine-needle aspiration biopsy (FNA) are the 
preferred diagnostic methods, but both procedures 
have serious limitations. These limitations are especially 
serious in the case of nodules with equivocal FNA re-
sults, which can constitute up to 30% of all examined 
nodules. They are particularly related to follicular 
lesions (FL) [1, 2]. The current Bethesda classification 
of cytological diagnoses distinguishes two categories 
among FL: III — follicular lesion of undetermined 
significance (FLUS) and IV — suspicious for follicular 
neoplasm (SFN). In the case of category IV the risk 
of malignancy in a nodule is usually over 15% and 
a surgical treatment is recommended [1]. But in areas 
of iodine deficiency or in post-endemic areas that risk 
may be lower (due to non-neoplastic hyperplastic fol-
licular nodules outnumbering follicular neoplasms), 
and then the decision on the surgical treatment becomes 
less obvious [3, 4]. The risk of malignancy of category 
III is more diverse and it ranges from 5% to as much as 
50% [5–9] among various centres. This is in contrast to 
the assumptions that were made when that category 
was created. According to them, category III should 
isolate nodules with lower risk of malignancy from 
other FL. The management of those nodules should 
be based on repeated FNA [2]. Unfortunately, both 
in centres reporting low and high malignancy risk in 
FLUS nodules, the repeated FNAs are inconclusive in 
20–30% of cases — because of recurrent FLUS result or 
non-diagnostic smears [7, 8, 10]. Molecular diagnostics 
performed with repeated FNA is neither efficient nor 
easily accessible [1, 11]. Analysis of classic ultrasound 
malignancy risk features (UMRFs) usually does not 
improve cancer detection in FL nodules either. Our 
previous studies showed that the efficiency of UMRFs 
analysis decreases with the lowering percentage of pap-
illary cancers (PTCs) among malignant tumours [12]. 
This should not be surprising because the identifica-
tion of UMRFs was particularly based on the analysis 
of the most common PTCs [13, 14]. Ultrasound images 
of these cancers differ from the images of follicular 
cancers (FTC) [15], which are more common among 
malignant FL than among other nodules, especially in 
iodine deficient populations.
The aforementioned limitations of US and FNA are 
sought to be overcome by finding new US parameters. 
Elastography is thought to be a promising technique 
in this area. This method, depending on its type and 
the employed image analysis technique, may provide 
a qualitative or quantitative assessment of the nodule 
stiffness/hardness, which is the accepted malignancy 
risk feature of a tumour. The most popular and widely 
used elastography technique is strain elastography 
(SEG), which allows analysis of a colour map of the 
nodule stiffness and assessment of the relative nodule 
stiffness in comparison to its surroundings. Elastogra-
phy was successfully applied to the thyroid gland in 2005 
[16]. Since then, several studies on the usefulness of elas-
tography in the diagnosis of TNs have been reported; 
however, clear conclusions have not been established 
yet. The majority of authors state that elastography 
may assist conventional methods in the diagnostics of 
thyroid nodules [17–22], and it may be helpful in diag-
nosing thyroiditis [23], especially in the differentiation 
of nodules in patients with chronic thyroiditis [23, 24]. 
Nevertheless, in the opinion of some authors the use-
fulness of SEG is limited [25–27], especially in patients 
with multinodular goitre [28]. In such cases shear wave 
elastography may be a useful tool for quantitative elas-
tographic measurements [29]. Some reports confirmed 
SEG efficiency in relation to FL [30–32]. However, most 
of them indicate that further studies are still required 
[33–35]. In the majority of those studies the influence 
of particular types of thyroid cancer on the obtained 
results was not considered. The ratio of PTCs to other 
cancers in FL nodules differed among reporting centres.
Therefore, the aim of our study was to establish the 
usefulness of SEG in two groups of TNs: nodules with 
unequivocal cytology (UC), where PTCs dominate, and 
nodules in FL group, where the percentage of PTCs is 
markedly lower.
Material and methods
SEG was performed in patients with TNs subjected to 
FNA in our centre in the years 2013–2015. The exami-
ned nodules had at least one malignancy risk factor 
(ultrasonographic or clinical), or they were the largest 
nodules in the thyroid, while no other lesion was more 
suspicious. A detailed description of the FNA procedure 
was presented in our earlier report [8]. Results of FNA 
were classified into six groups defined in the Bethesda 
system [2]. SEG was performed in all of the nodules 
with the FNA outcome corresponding to FL, i.e. cate-
gories III (FLUS) or IV (SFN) in the Bethesda system, 
and in UC nodules: all of the nodules with category VI 
(malignant neoplasm — MN) and similar number of 
subsequent nodules with an FNA result of category II 
(benign lesion — BL). The exclusion criteria were as fol-
lows: the nodule diameter wider than the width of the 
transducer, the presence of eggshell calcifications, more 
than 50% of the cystic content, another superficially 
located nodule, and absence of surrounding reference 
thyroid tissue (free of pathological lesions). Additionally, 
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the following clinical exclusion criteria were used: prior 
treatment for thyroid cancer, radioiodine therapy, thy-
roid surgery, neck irradiation, and a massive thyroid 
fibrosis in the course of Hashimoto disease. Eventu-
ally, the analysis included only TNs with the available 
postoperative histopathological result. It was the basis 
for the selection of malignant and benign nodules in 
both groups (FL and UC). Patients with the cytological 
outcome SFN or MN were routinely referred for surgi-
cal treatment. The decision on the surgical treatment in 
the patients with FLUS or BL result was based on the 
patient’s preferences (in the majority of cases) or on 
the presence of clinical risk features (e.g. the nodule 
enlargement).
In total, 68 FL nodules were analysed: 34 SFN and 
34 FLUS. Cancers were found in 11.8% of FLs, includ-
ing two FLUS nodules (5.9%) and six SFN nodules 
(17.6%). Among the revealed cancers there were four 
(50.0%) PTCs, two (25.0%) FTCs, including one case of 
oxyphylic type (FTC-O), and two (25.0%) medullary 
cancers (MTC). The UC group included 100 nodules: 
50 subsequently examined, cytologically and histo-
pathologically benign nodules, as well as 50 cancers, 
including 45 (90.0%) PTCs (p = 0.018 vs. FL group), 
four (8.0%) MTC, and one (2.0%) FTC-O. There were 
no differences in the mean age of patients between 
the groups: FL group — 54.3 ± 12.8 years; UC group 
— 52.9 ± 13.8 years (p = 0.523). In the UC group the 
patients with cancers were significantly younger than 
the patients with benign nodules: 49.0 ± 15.3 vs. 56.7 
± 11.2 years (p = 0.005), while in the FL group such 
differences were not observed: 59.0 ± 15.5 vs. 53.7 ± 
12.5 years, respectively (p = 0.271). The percentage 
of males in both groups was similar: FL — 10.3%, UC 
— 12.0% (p = 0.731). The mean nodule volume was 
also similar: FL — 2.5 ± 3.5 mm3, UC — 1.7 ± 3.4 mm3 
(p = 0.079).
Conventional US and SEG were accomplished us-
ing an Aloka Prosound Alpha 7 sonograph, ALOKA co. 
Ltd., Tokyo, Japan with a 7.5–14 MHz linear transducer, 
power Doppler functionality, and Hitachi software for 
the elastography. Elastography examinations were 
performed using the real-time compression method. 
Freehand, delicate compression was applied to the neck. 
The pressure level and its regularity were controlled 
by a five-point scale — the applied pressure was kept 
between levels 3 and 4. The colour map of tissue stiff-
ness — the elastogram — was analysed and classified 
using the four-grade elasticity scale (elasticity score — ES) 
developed by Asteria et al. [36]: score 1 — elasticity in 
the whole nodule (entirely green), score 2 — elasticity in 
a large part of the nodule (mostly green with some blue 
parts), score 3 — no elasticity in a large part of the nod-
ule (mostly blue with some green parts), score 4 — no 
elasticity in the whole nodule (entirely blue). Further-
more, the strain ratio (SR) was measured as the relative 
nodule stiffness compared to the reference thyroid area 
(shown in the same image, with no pathological lesions). 
This area was kept similar in size to the examined nod-
ule and had a similar distance from the skin (Fig. 1–3). 
The measurements were performed in transverse (tES 
and tSR) and longitudinal (lES and lSR) sections. Mean 
(meanES, meanSR) and maximal values (maxES and 
maxSR) of those variables in both sections were also 
analysed. The results of SEG were compared with the 
analysis of the number of conventional UMRFs (NoUM-
RFs) present in the nodule (ranging from 0 to 5), which 
included: 1) hypoechogenicity or marked hypoecho-
genicity (compared with the surrounding thyroid or 
strap muscles) of a solid nodule (< 25% cystic), 2) more-
tall-than-wide shape (measured on the transverse view), 
3) pathological vascularisation — chaotic intra-nodular 
vascular spots, 4) suspicious margins — irregular or 
blurred or suggesting extra-thyroidal extension, and 
5) microcalcifications. Such a design was related to the 
fact that current recommendations concordantly admit 
that none of the single UMRF has sufficient accuracy. 
There is also a diversity of suggested sets of UMRFs, 
and none of them is widely accepted [1, 13, 37, 38]. The 
only non-disputable point is that the higher number of 
UMRFs in the nodule, the higher risk of its malignancy.
The efficacy of examined elastographic parameters 
(tES, tSR, lES, lSR, meanES, mean SR, max ES, and 
max SR) and of the NoUMRFs in the differentiation 
between benign lesions and cancers was assessed 
by analysis of the receiver operating characteristics 
curve (ROC) and the area under the ROC (AUC) 
value. That method was also applied to calculate the 
cut-off values of examined parameters characterised 
by optimal sensitivity (SEN) and specificity (SPC), 
meant as the highest possible sum of SEN and SPC. 
The thresholds were determined for the ES and SR 
parameters which showed the highest AUC values on 
the condition that AUC was above 0.7. The effective-
ness of the determined thresholds in both groups was 
presented as SEN, SPC, the accuracy (ACC), the posi-
tive predictive value (PPV), the negative predictive 
value (NPV), and the positive likelihood ratio (LR+). 
The odds ratio (OR) for the established cut-off values 
and the efficacy of combinations of ES, SR, and NoUM-
RFs were assessed with the use of logistic regression 
analysis. The comparison of frequency distributions 
was performed with the χ2 test (with suitable modi-
fications according to the number of analysed cases), 
and the Kruskal-Wallis test was used for comparison 
of continuous variables between groups. The statisti-
cal analysis was performed with Statistica version 10 
statistical software. The value of 0.05 was assumed as 
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Figure 1. Benign lesion: B-mode and 
elastographic image,  NoUMRFs — 1 
(hypoechogenicity), ES — 2, SR — 1.07
Rycina 1. Zmiana łagodna: obraz w pre-
zentacji B i elastogram, NoUMRFs — 1 
(hipoechogeniczność), ES — 2, SR — 1,07
Figure 2. Follicular lesion of undetermined 
significance: B-mode and elastographic image; 
NoUMRFs — 2 (hypoechogenicity, irregular 
margin), ES — 2, SR — 1.69
Rycina 2. Zmiana pęcherzykowa bliżej 
nieokreślona: obraz w prezentacji B i elastogram; 
NoUMRFs — 2 (hipoechoegeniczność, 
nieregularne granice), ES — 2, SR — 1,69
Figure 3. Malignant neoplasm: B-mode 
and elastographic image; NoUMRFs — 3 
(hypoechogenicity, irregular margin, taller-
than-wide shape), ES — 4, SR — 5.0
Rycina 3. Nowotwór złośliwy: obraz 
w prezentacji B i elastogram; NoUMRFs — 3 
(hipoechoegeniczność, nieregularne granice, 
kształt wyższy niż szerszy), ES — 4, SR — 5,0
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the level of significance. The study protocol had been 
approved by the local Bioethics Committee. All the 
patients gave their informed consent.
Results
Table I shows the distribution of particular ES as well 
as the mean and the median SR in patients in UC and 
FL groups in relation to the result of the postoperative 
histopathological examination. In the UC group the 
nodules were soft (ES1 or ES2) less often among cancers 
than among benign lesions and were hard (ES3 or ES4) 
more often (only in the case of lES1 the difference was 
insignificant — p = 0.074). In the FL group, no signifi-
cant differences were found in the distribution of ES 
between cancers and benign lesions. Cancers in the 
FL group showed ES3 or ES4 less often than cancers in 
the UC group (32.5% vs. 88.0% in the transverse sec-
tion, p = 0.004 and 25.0% vs. 82.0% in the longitudinal 
section, p = 0.003), and none of the cancers in the FL 
group showed ES4. Normal elasticity (meant as ES1) 
was found concomitantly in both sections in a single 
cancer (2.0%) of the UC group and in no cancer of the 
FL group. The mean value of SR was significantly higher 
in cancers than in benign lesions in the UC group, while 
in the FL group no such difference was observed. In 
the longitudinal section the cancers of the FL group 
showed significantly lower mean SR than cancers of 
the UC group (lSR: p = 0.007)
Table II shows the distribution of the NoUMRFs in 
examined groups. In the UC group, cancers showed 
3 UMRFs and above 2 UMRFs (p < 0.001) more often 
than benign lesions, and 1 UMRF and under 2 UMRFs 
(p < 0.001) less often than benign lesions. The FL group 
did not show similar regularity. The distribution of the 
NoUMRFs in benign lesions in both groups was similar, 
but it differed between cancers: above 2 UMRFs were 
found in 44.0% of cancers in the UC group, but in none 
cancer of the FL group (p = 0.047).
Table III shows the comparison of the classification 
value of particular SEG parameters and the NoUMRFs 
in both groups. In the UC group, AUC values for all 
elastographic parameters were higher than 0.8 and did 
not differ significantly. In the analysis of both ES and SR, 
the highest AUC was noted for meanES and meanSR, 
respectively. The AUC value for both of those param-
eters was significantly higher than for the NoUMRFs 
(meanSR: p = 0.006, meanES: p = 0.029). The thresholds 
determined for those parameters with the use of ROC 
curves were: 2.5 for meanES, 2.01 for meanSR, and 2 for 
the NoUMRFs (Fig. 4). In the FL group the highest AUC 
values were found for tSR and tES, but the value of AUC 
exceeded 0.7 only for tSR. The threshold determined 
for tSR was 1.7 (Fig. 4).
Table IV shows the values describing the diagnostic 
efficacy of the determined thresholds in both groups. 
In the UC group the analysis based on meanSR ≥ 2.01 
showed significantly higher SPC (p = 0.027), ACC 
(p = 0.003), PPV (p = 0.030), and NPV (p = 0.048) 
and a lower percentage of FP results (p = 0.038) in 
comparison to the NoUMRFs ≥ 2 criterion. Nearly 
significant differences were observed for SEN (p = 
0.054) and the percentage of FN results (p = 0.070). 
The analysis based on meanES ≥ 2.5 showed signifi-
cantly higher SEN (p = 0.027) and ACC (p = 0.047) 
and a lower percentage of FN results (p = 0.038) in 
comparison to the NoUMRFs ≥ 2 criterion. The dif-
ference was nearly significant for NPV (p = 0.057). 
No statistically significant differences were found 
for SEN, SPC, ACC, PPV, or NPV between meanES 
≥ 2.5 and meanSR ≥ 2.01 criteria, but the LR+ value 
was nearly two-fold higher for meanSR ≥ 2.01 than 
for meanES ≥ 2.5 (7.2 vs. 3.7). The logistic regression 
analysis confirmed that all of the analysed criteria were 
significantly related to thyroid malignancy in the UC 
group, but only meanSR ≥ 2.01 was an independent 
malignancy risk factor. The addition of other criteria to 
meanSR did not improve the diagnostic efficiency of 
the test as measured with AUC (Tables V and VI). OR 
values slightly higher than those noted for the isolated 
meanSR ≥ 2.01 criterion were observed only in two 
models: the conjunction of both elastographic criteria, 
i.e. meanES ≥ 2.5 and meanSR ≥ 2.01 (Table V) as well 
as the inclusive disjunction of the NoUMRFs ≥ 2 and 
meanSR ≥ 2.01 criteria (Table VI). The former model 
had values of SEN and SPC similar to the single crite-
rion of meanSR ≥ 2.01. The inclusion of the NoUMRFs 
≥ 2 criterion to this model markedly lowered SEN — to 
60.0%, but increased SPC to 92.0%. High SPC could be 
also obtained with the conjunction of the NoUMRFs 
≥ 2 and meanSR ≥ 2.01 criteria, while the inclusive 
disjunction of the criteria led to maximal SEN (96.0%). 
The model with maximal SEN was connected with 
a need for biopsy of twice as many nodules compared 
to the model with maximal SPC (65.0% vs. 34.0%, 
p < 0.001).
In the FL group the models based on meanES ≥ 2.5, 
meanSR ≥ 2.01, and NoUMRFs ≥ 2 criteria were not ef-
ficient (LR+ in the range of 1.2–1.4, SEN did not exceed 
50%). The model based on tSR ≥ 1.7 criterion also had 
low LR+ (2.5), but with SEN: 75.0% and PPV: 24.0%. 
The tSR ≥ 1.7 criterion was related to the increased risk 
of malignancy in FL nodules in a nearly significant way 
(OR: 8.6, p = 0.065) (Table IV), similarly to the model 
based on conjunction of tSR ≥ 1.7 and NoUMRFs ≥ 2 
criteria (OR: 6.6, p = 0.071) (Table V). That combination 
showed higher SPC than models based on single tSR 
≥ 1.7 or single NoUMRFs ≥ 2 criterion (respectively, 
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85.0% vs. 68.3% and 58.3%, p = 0.031 and p = 0.001), 
but the SEN of that combination was low (37.5%). The 
inclusive disjunction of those criteria did not improve 
the SEN of the model in comparison to isolated tSR ≥ 
1.7 criterion and had lower SPC (41.7% vs. 68.3%, p = 
0.003). Optimal SEN and SPC at the level of 75.0% were 
simultaneously observed in the model based on the 
conjunction of tSR ≥ 1.7 and UMRFs ≥ 1 criteria. These 
criteria were matched by 30.9% of the nodules that 
should be potentially diagnosed by FNA. The logistic re-
gression analysis confirmed that the risk of malignancy 
of those nodules was significantly higher (OR: 12.0, 
p = 0.034). The inclusive disjunction of those criteria 
led to SEN reaching 100.0%, but was accompanied with 
low SPC (16.7%) and a very high percentage of nodules 
matching any of the criteria (85.3%).
Figure 4. ROC curves for the classification of benign and malignant lesions using analysis of: A. number of ultrasound malignancy 
risk features (NoUMRFs); B. mean values of elasticity score in both sections (meanES); C. mean values of strain ratio in both sections 
(meanSR); D. strain ratio measured in transverse section (tSR)
Rycina 4. Krzywe ROC w różnicowaniu zmian łagodnych i złośliwych wyznaczone dla wartości: A. liczby ultrasonograficznych 
cech ryzyka złośliwości (NoUMRFs) w grupie UC; B. średniej wartości w punktowej skali oceny klasy elastogramu z obu przekojów 
(meanES) w grupie UC; C. średniej wartości wskaźnika odkształcenia z obu przekojów (mean SR) w grupie UC; D. wartości wskaźnika 
odkształcenia na przekroju poprzecznym (tSR) w grupie FL
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Table I. Results of elastographic evaluation of the nodules in FL and UC groups in relation to the eventual histopathological 
diagnosis
Tabela I. Wyniki badania elastograficznego ognisk z grup FL i UC w zależności od ostatecznego rozpoznania histopatologicznego
Parameters The category of FNA
UC (100) FL (68)
Histopathological results
Benign (50) 
No/%
Malignant (50) p Benign (60) 
No/%
Malignant (8) p
No/% No/%
ES
Transverse 
section
tES1 [n/%] 15/30.0 1/2.0 0.005 15/25.0 0/0.0 0.251
tES2 [n/%] 23/46.0 5/10.0 < 0.001 27/45.0 5/62.5 0.579
tES3 [n/%] 12/24.0 36/72.0 < 0.001 18/30.0 3/32.5 0.981
tES4 [n/%] 0/0 8/16.0 0.009 0/0 0/0 –
tES [Me 
(Q:25–75)]
2.0 (1.0–2.0) 3.0 (3.0–3.0) < 0.001 2.0 (2.0–2.0) 2.0 (2.0–3.0) 0.231
Longitudinal 
section
lES1 [n/%] 10/20.0 3/6.0 0.074 9/15.0% 1/12.5% 0.731
lES2 [n/%] 30/60.0 6/12.0 < 0.001 36/60.0% 5/62.5% 0.804
lES3 [n/%] 10/20.0 29/58.0 < 0.001 14/23.3% 2/25.0% 0.734
lES4 [n/%] 0/0.0 12/24.0 < 0.001 1/1.7% 0/0.0% 0.232
lES [Me 
(Q:25–75)]
2.0 (2.0–2.0) 3.0 (3.0–3.0) < 0.001 2.0 (2.0–2.0) 2.0 (2.0–2.5) 0.893
SR  
Transverse 
section
tSR [x ± SD] 1.4 ± 0.6 3.6 ± 1.7 < 0.001 1.7 ± 1.3 2.8 ± 1.8 0.102
tSR [Me 
(Q:25–75)]
1.3 (1.0–1.6) 3.3 (2.3–4.7) 1.3 (0.8–2.1) 1.8 (1.7–4.5)
Longitudinal 
section
lSR [x ± SD] 1.5 ± 0.8 3.3 ± 1.7 < 0.001 1.6 ± 1.2 1.8 ± 1.4 0.478
lSR [Me 
(Q:25–75)]
1.2 (1.0–1.9) 3.3 (2.1–4.0) 1.3 (0.9–1.7) 1.4 (1.2–1.6)
Table II. Number of UMRFs in the nodules of FL and UC groups in relation to the eventual histopathological diagnosis
Tabela II. Liczba UMRFs w ogniskach z grup FL i UC w zależności od ostatecznego rozpoznania histopatologicznego
NoUMRFs The category of FNA
UC (100) FL (68)
Histopathological results
Benign (50) Malignant (50) p Benign (68) Malignant (8) p
No/% No/% No/% No/%
0 [n/%] 11/22.0 4/8.0 0.093 13/21.7 0/0 0.324
1 [n/%] 24/48.0 11/22.0 0.006 22/36.7 4/50.0 0.733
2 [n/%] 12/24.0 13/26.0 0.817 19/31.7 4/50.0 0.527
3 [n/%] 3/6.0 16/32.0 0.002 6/10.0 0/0 0.785
4 [n/%] 0/0 5/10.0 0.066 0/0 0/0 —
5 [n/%] 0/0 1/2.0 1.0 0/0 0/0 —
Me (Q:25–75) 1.0 (1.0–2.0) 2.0 (1.0–3.0) < 0.001 1.0 (1.0–2.0) 1.5 (1.0–2.0) 0.494
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Table III. Comparison of the classification value of elastographic parameters and of the number of UMRFs in FL and UC groups
Tabela III. Porównanie wartości klasyfikacyjnej kolejnych parametrów elastograficznych oraz liczby UMRFs w grupach FL i UC
Parameter The category of FNA
UC FL
AUC SE 95% Cl p AUC SE 95% Cl p
NoUMRFs 0.754 0.049 0.658–0.849 < 0.001 0.571 0.085 0.404–0.737 0.404
ES
tES 0.845 0.040 0.766–0.924 < 0.001 0.622c 0.088 0.449–0.795 0.167
lES 0.823 0.044 0.737–0.909 < 0.001 0.513 0.107 0.303–0.723 0.904
meanES 0.869a 0.036 0.798–0.940 < 0.001 0.568 0.096 0.380–0.758 0.479
maxES 0.856 0.038 0.783–0.932 < 0.001 0.532 0.100 0.337–0.728 0.746
SR
tSR 0.898a 0.039 0.822–0.974 < 0.001 0.725d 0.112 0.505–0.945 0.045
lSR 0.860 0.038 0.784–0.935 < 0.001 0.578 0.087 0.407–0.749 0.371
meanSR 0.903b 0.032 0.840–0.965 < 0.001 0.597e 0.091 0.419–0.774 0.285
maxSR 0.893a 0.033 0.828–0.958 < 0.001 0.536 0.105 0.330–0.743 0.729
ap < 0.05 — vs. NoUMRFs; bp < 0.01 — vs. NoUMRFs; cp < 0.0001 — vs. maxES; dp < 0.005 — vs. tES, maxES; ep < 0.05 — vs. maxSR
Discussion
For the last decade, interest in applying elastography 
to thyroid diagnostics has been increasing. The cur-
rent recommendations indicate elastography as an 
optional method that needs further studies [1, 4, 36]. 
An important obstacle is the lack of standardisation of 
elastographic measurements, which makes it impossible 
to adopt common thresholds for both ES and SR values. 
Our data show that the necessity of local thresholds for 
ES and SR is also related to the specificity of examined 
nodules. Specific criteria are necessary especially for 
FL that are characterised by low risk of malignancy 
and relatively low percentage of PTC among cancers.
We found that in the UC group (with a high percent-
age of PTC among cancers) the elastography had higher 
diagnostic efficacy than the assessment of NoUMRFs, 
both ES and SR. The efficacy of SEG in longitudinal 
and transversal sections is similar, but the evaluation 
of mean ES and SR values of both sections is the most 
effective. The criterion of meanSR ≥ 2.01 is an independ-
ent risk factor of malignancy in the nodule. However, in 
the case of lack of a suitable reference area the criteria 
based on ES evaluation can be used. These criteria also 
indicate significantly increased risk. The determined 
threshold for meanES, i.e. meanES ≥ 2.5, leads to the 
conclusion that ES4 found in any section is a malignancy 
risk factor regardless of the value measured in the other 
section (similarly to the ES3 accompanied by any score 
>1 in the other section).
Similar observations that indicate the advantage of 
SR evaluation over UMRFs analysis were made in the 
studies carried out in populations with a high percent-
age of PTCs among thyroid cancers. Xing et al. [21] 
indicated that both SEG parameters, but especially SR, 
were more reliable than the analysis of single UMRFs. 
The advantage of SR and ES was shown also by Ning et 
al. [39], Wang et al. [40], as well as in the meta-analysis 
by Sun et al. [41], but it was not confirmed by Chong et 
al. [42]. Less coherent observations were made on the 
effectiveness of ES analysis. Azizi et al. [17] showed that 
the ES analysis stratifies the malignancy risk of thyroid 
nodules with the PPV equal to microcalcifications and 
higher than other UMRFs. The high usefulness of ES 
analysis in the differentiation between benign and ma-
lignant thyroid nodules was also reported by Hong at 
al. [20]. Interestingly, Mehrorta et al. [43] showed that 
the ES measurement might be helpful in the selection 
of benign nodules only due to high NPV and SPC, but 
it was related to low PPV. Shuzhen [44] demonstrated 
higher NPV, SPC, and ACC but lower SEN for ES in com-
parison with UMRFs analysis. Our study also showed 
higher NPV of ES evaluation than of NoUMRF analysis, 
with similar SPC, but higher SEN and ACC. It should 
be remembered that the direct comparison of PPV and 
NPV values originating from various centres is difficult 
because these parameters depend on the general risk of 
cancer in thyroid nodules in the examined population. 
On the other hand, Unlütürk et al. [27] did not find any 
superiority of ES over classic US. Moon et al. [26] even 
showed that URMF analysis had a distinct advantage 
over ES evaluation in diagnosing thyroid cancers. In 
spite of these discrepancies some authors underline 
the significance of the lowest elasticity score (ES1) in 
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Table IV. Indexes of the diagnostic efficacy of the determined thresholds for the number of UMRFs and elastographic parameters 
— comparison between UC and FL
Tabela IV. Wartości wskaźników opisujących skuteczność diagnostyczna ustalonych progów odcięcia dla liczby UMRFs oraz 
parametrów elastograficznych — porównanie grup UC i FL
The category of FNA
UC FL
NoUMRFs  
≥ 2
meanES 
≥ 2.5
meanSR 
≥ 2.01
NoUMRFs  
≥ 2
meanES 
≥ 2.5
meanSR 
≥ 2.01
tSR 
≥ 1,7
NoUMRFs 
≥ 1
TP [n/%] 35/35.0 44/44.0 43/43.0 4/5.9 3/4.4 2/2.9 6/8.8 8
TN [n/%] 35/35.0 38/38.0 44/44.0 35/51.5 39/57.4 49/72.1a 41/60.3 13
FP [n/%] 15/15.0 12/12.0 6/6.0a 25/36.8 21/30.9 11/16.2a, c 19/27.9 47
FN [n/%] 15/15.0 6/6.0a 7/7.0 4/5.9 5/7.4 6/8.8 2/2.9 0
SEN [%] 70.0 88.0a 86.0 50.0 37.5 25.0 75.0 100.0
SPC [%] 70.0 76.0 88.0a 58.3 65.0 81.7b 68.3 21.7
ACC [%] 70.0 82.0a 87.0b 57.4 61.8 75.0 69.1 30.9
PPV [%] 70.0 78.6 87.8a 13.8 12.5 15.4 24.0 14.5
NPV [%] 70.0 86.4 86.3a 89.7 88.6 89.1 95.3 100.0
LR+ 2.3 3.7 7.2 1.2 1.2 1.4 2.5 1.3
OR 
(95% Cl) 
P
Univariate 
analysis
5.4 
(2.3–12.8) 
< 0.001
23.2 
(8.0–67.8) 
< 0.001
45.0 
(14.0–144.9) 
< 0.001
1.4 
(0.3–6.3) 
0.655
1.1 
(0.2–5.3) 
0.889
1.5 
(0.3–8.6) 
0.654
8.6 
(0.8–89.2) 
0.065
—
Multivariate 
analysis
2.7 (0.8–9.3) 
0.103
2.3 (0.5–11.4) 
0.294
20.3 (4.3–96.1) 
< 0.001
— — — — —
ap < 0.05 — vs. NoUMRFs; bp < 0.01 — vs. NoUMRFs; cp < 0.05 — vs. meanES
Table V. Analysis of selected conjunctions of the elastographic parameters and the number of UMRFs in differentiation between 
benign and malignant lesions in UC and FL groups
Tabela V. Analiza koniunkcji parametrów elastograficznych i liczby UMRFs w różnicowaniu zmian łagodnych i nowotworów 
złośliwych w grupach UC i FL
The category of FNA
UC FL
NoUMRFs ≥ 2 & 
meanES ≥ 2.5
NoUMRFs ≥ 2 & 
meanSR ≥ 2.01
meanES ≥ 2.5 & 
meanSR ≥ 2.01
NoUMRFs ≥ 2 & 
meanES ≥ 2.5 & 
meanSR ≥ 2.01
NoUMRFs ≥ 1 & 
tSR ≥ 1.7
NoUMRFs ≥ 2 & 
tSR ≥ 1.7
SEN [%] 64.0 60.0 84.0 60.0 75.0 37.5
SPC [%] 88.0 92.0 90.0 92.0 75.0 85.0
ACC [%] 76.0 76.0 87.0 76.0 75.0 79.4
PPV [%] 84.2 88.2 89.4 88.2 28.6 25.0
NPV [%] 71.0 69.7 84.9 69.7 95.7 91.1
LR+ 5.3 7.5 8.4 7.5 3.2 2.5
OR 
(95% Cl) 
p
13.0 
(4.7–36.5) 
< 0.001
17.3 
(5.4–55.5) 
< 0.001
47.3 
(14.3–155.9) 
< 0.001
17.3 
(5.4–55.5) 
< 0.001
12.0 
(1.1–119.1) 
0.034
6.6 
(0.8–55.4) 
0.071
% of all nodules 38.0 34.0 47.0 34.0 30.9 17.7
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the identification of benign nodules [27, 43], which is 
concordant with our results.
Few reports are related to the usefulness of SEG in 
the nodules with an equivocal FNA result. The com-
parison of the studies on this group of nodules is dif-
ficult because of epidemiological differences between 
the examined populations, mainly in the iodine supply. 
These differences are particularly important in such 
nodules because iodine supply not only modifies the 
malignancy risk in FL but also influences the relation 
between the numbers of PTCs and FTCs. Another is-
sue is related to the discrepancies in the qualification 
of nodules into the FLUS category. In our population 
the incidence of malignancy in FL nodules, as deter-
mined with histopathological examinations, is low 
(below 20%) [4]. As a consequence of the long-term 
iodine deficiency (successfully corrected for the last 20 
years), non-neoplastic lesions still dominate among FL, 
while FTCs constitute a significant fraction of cancers. 
Such a profile of cancers in FL is also a consequence 
of the conservative attitude to the FLUS category. In 
our country, this diagnosis is formulated mainly in the 
case of smears located on the border between follicular 
neoplasms and non-neoplastic lesions [4]. In many 
other centres the FLUS category includes similar num-
bers of smears from the border between a suspected 
malignancy and a non-diagnostic specimen. Therefore, 
the risk of malignancy in FLUS nodules increases up 
to 50% and the percentage of PTCs among revealed 
cancers is higher [5, 9].
In our study, both SEG and classic US parameters 
showed lower diagnostic efficacy in the FL group than 
in the UC group. Only SR evaluation in the transverse 
section might be potentially useful (AUC > 0.7), and 
tSR values ≥ 1.7 increased nearly twice the risk of ma-
lignancy in that group. The SEG criteria determined in 
the UC group showed very low SEN in FL nodules. This 
was because of differences in the elastographic image 
of cancers between FL and UC groups. These observa-
tions are concordant with some reports suggesting 
that the stiffness of PTCs may differ from the stiffness 
of other thyroid cancers (including FTC and MTC) on 
the basis of ES evaluation [19, 27, 43, 44] or — less often 
— SR evaluation [45]. We did not find any differences 
between benign lesions in both groups. Consequently, 
the elastographic criteria determined in the UC group 
(especially meanSR ≥ 2.01) showed only slightly lower 
SPC in the FL group, and may be utilised to identify 
benign nodules among FL. The ES1 can be used for the 
same purpose just like in UC nodules. This conclusion 
is concordant with the results of the meta-analysis by 
Veer and Puttagunta [46], which led to the statement 
that in the case of the low malignancy risk in nodules 
with an equivocal or non-diagnostic cytology a normal 
elastogram should indicate conservative treatment.
Other reports on the effectiveness of SEG and 
especially of ES evaluation in the group of nodules 
with equivocal cytology (including FL) are not coher-
ent. Rago et al. [31] showed that ES analysis is more 
useful than the UMRFs examination in indeterminate 
Table VI. Analysis of the selected inclusive disjunctions of elastographic parameters and the number of UMRFs in the 
differentiation between benign and malignant lesions in UC and FL groups
Tabela VI. Analiza alternatywnych kombinacji parametrów elastograficznych i liczby UMRFs w różnicowaniu zmian 
łagodnych i nowotworów złośliwych w grupach UC i FL
The category of FNA
UC FL
NoUMRFs ≥ 2 or 
meanES ≥ 2.5
NoUMRFs ≥ 2 or 
meanSR ≥ 2.01
meanES ≥ 2.5 or 
meanSR ≥ 2.01
NoUMRFs ≥ 2 or
meanES ≥ 2.5 or 
meanSR ≥ 2.01
NoUMRFs ≥ 1 or 
tSR ≥ 1.7
NoUMRFs ≥ 2 or 
tSR ≥ 1.7
SEN [%] 94.0 96.0 90.0 96.0 100.0 75.0
SPC [%] 58.0 66.0 74.0 56.0 16.7 41.7
ACC [%] 76.0 81.0 82.0 76.0 26.5 45.6
PPV [%] 69.1 73.8 77.6 68,6 13.8 14.6
NPV [%] 90.6 94.3 88.1 93.3 100.0 92.6
LR+ 2.2 2.8 3.5 2.2 1.2 1.3
OR 
(95% Cl) 
p
21.6 
(5.9–79.0) 
< 0.001
46.6 
(10.1–215.3) 
< 0.001
25.6 
(8.4–78.5) 
< 0.001
30.5 
(6.7–139.8) 
< 0.001
— 3.3 
(0.3–34.3) 
0.298
% of all nodules 68.0 65.0 58.0 70.0 85.3 60.6
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nodules. On the other hand, Lippolis et al. [33] and 
Vidal-Casariego et al. [34] did not confirm the diagnostic 
usefulness of the elastogram assessment in such no-
dules. The meta-analysis by Trimboli et al. [47] came to 
the conclusion that ES analysis alone should not be used 
for selecting patients for surgery, which is concordant 
with our observations. There is a dominating opinion 
on the advantage of SR analysis over ES evaluation also 
in the group of nodules with equivocal cytology. Cakir 
et al. [30] showed that SR examination allowed the de-
tection of cancers with higher ACC than ES analysis in 
patients with FNA outcomes “atypia of undetermined 
significance” (AUS — a subgroup of FLUS with nuclear 
atypia and higher risk of cancer than classic FLUS, as 
well as higher percentage of PTCs among cancers). 
Cantisani et al. [32] reported that SR evaluation signifi-
cantly increased the ACC of US examination, both in 
comparison with particular UMRFs and their number. 
Conversely, Seong et al. [48] found that neither ES 
evaluation nor SR analysis was useful in the diagnostics 
of nodules with indeterminate cytology.
The last question is related to the studies on the 
combination of SEG and classic US. In our study, we 
found that their combination showed no substantial 
advantage over isolated SR evaluation as measured 
with AUC. However, the model based on the inclusive 
disjunction of SR criterion and the NoUMRFs gives 
a test with maximal SEN, while the conjunction of these 
criteria results in maximal SPC. When the SR analysis 
is impossible (no suitable reference area) similar effects 
may be obtained with analogical combinations of ES 
analysis and the NoUMRF. In the FL group the optimal 
SEN and SPC (75.0% both) can be accomplished with 
the conjunction of at least 1 UMRF with the suspected 
SR value. Such a model was the only one that increased 
the risk of malignancy in a nodule of the FL group to 
a level suggesting surgical treatment.
The comparison of the studies with regard to the 
combination of SEG and US criteria is difficult because 
of various ways of their combination. In the study on 
nodules with both unequivocal and equivocal cytology 
(but with PTC domination and without FL nodules) 
Moon et al. [26] did not find any positive effect of the 
combination of UMRFs and ES examination. They 
analysed the number of malignancy risk features 
including both US and SEG analysis. Shao et al. [49] 
found that the combination of ES and the NoUMRFs 
significantly improved the discriminating value of 
each (their study included nodules with PTC predomi-
nating among cancers). Unlütürk et al. [27] reported 
that the combination of ES and single UMRF slightly 
increased SEN and PPV of SEG as well as SPC and 
ACC of UMRF analysis in the group of non-preselected 
nodules (with PTCs > 90% of all cancers). Trimboli et 
al. [50] also analysed non-preselected thyroid nod-
ules (PTC > 90.0% of all cancers) and stated that the 
analysis of the presence of at least 1 UMRF or ES ≥ 3 
increased SEN and NPV of the test, but significantly 
decreased SPC, ACC, and PPV in comparison to the 
isolated analysis of those parameters. The increase 
in SEN and the decrease in SPC should be expected 
in such model, and the authors did not assess simul-
taneous occurrence of the analysed parameters. In 
FL nodules with 63.6% of PTCs among all cancers, 
Garino et al. [51] showed that the presence of at least 
two suspicious features either in US or SEG (they also 
evaluated ES) increased the risk of malignancy of the 
nodule to the level implying the surgical treatment.
The evaluation of SR was connected with UMRF 
analysis less often. Russ at al. [52] found that in no-
dules with unequivocal cytology the model based on 
the presence of suspected SR or suspected NoUMRFs 
improved SEN, but worsened SPC in comparison with 
the analysis of the NoUMRFs alone. Friedrich-Rust et al. 
[53] analysed non-preselected nodules and found that 
optimal SEN and SPC (85% and 68%) can be achieved 
in the model expecting the presence of at least four of 
the following features: ES ≥ 3, SR > 2.66, microcalcifica-
tions, macrocalcifications, no halo, irregular margins, 
and pathological pattern of the blood flow. According 
to our knowledge, none of the published reports as-
sessed the combination of SR and the NoURMFs in FL 
nodules, which was examined in our study.
There are some limitations related to the design of 
our study, which should be considered while interpret-
ing its results. First, it is the way of selecting nodules 
for the analysis on the basis of the postoperative histo-
pathological examination. It was necessary to establish 
a reliable diagnosis in FL nodules in which neither 
the control FNA nor the clinical follow-up allows to 
answer the diagnostic uncertainty. But the drawback 
of such a model is the nodule selection bias. To assure 
uniform design, the surgical treatment was mandatory 
in all of the nodules with unequivocal cytology. As 
was mentioned before, the elastographic evaluation 
is performed in various, non-uniform ways. Thus, in 
our study, following published data [16, 21, 27, 31, 36, 
44, 45, 53], and on the basis of our own experience, we 
specified the exclusion criteria and described precisely 
the applied measurement technique. Because the study 
included the comparison of the efficacy of ES and SR in 
both sections, it was limited to the nodules with a suit-
able reference area available in both sections at similar 
depth. A simple four-grade scale was employed for the 
classification of elastograms because it is characterised 
with good reproducibility [54]. It makes it unnecessary 
to perform sometimes difficult interpretation of the 
localisation of stiff regions (e.g. central vs. peripheral), 
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or to visualise the whole area around the lesion (which 
would exclude some nodules from the measurements). 
A limitation of our study is the low number of cancers 
in the FL group, but this number reflects the low risk 
of malignancy in such nodules in our population. 
It is indicated to confirm our observations in a higher 
number of malignant FL nodules.
Conclusions
Concluding, in UC nodules, with a predomination of 
PTCs among cancers, SEG (especially SR evaluation) 
shows a higher diagnostic efficacy than the analysis 
of NoUMRFs. The most effective parameter is the 
mean value of SR of both sections, but also SR and ES 
analysis performed in any section may be successfully 
used. The conjunction of a suspicious elastographic 
parameter (especially SR) with the presence of at least 
2 UMRFs provides the maximum SPC, while the inclu-
sive disjunction of the elastographic parameter with the 
NoUMRFs leads to maximal SEN.
In FL nodules with a low risk of malignancy and 
a low percentage of PTCs among cancers, SEG is less ef-
fective but still better than NoUMRFs analysis. Suspect-
ed SR values speak in favour of the surgical treatment, 
which allows us to obtain a certain diagnosis. On the 
other hand, low SR values and normal ES may be used 
to identify nodules with a very low risk of malignancy 
and to limit the number of so-called diagnostic surgeries 
performed when the clinical image is equivocal.
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